These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 6768438)

  • 81. Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.
    Prouse PJ; Kanski JJ; Gumpel JM
    Ann Rheum Dis; 1981 Dec; 40(6):564-6. PubMed ID: 6800311
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.
    Kvien TK; Høyeraal HM; Sandstad B
    J Rheumatol; 1985 Jun; 12(3):533-9. PubMed ID: 3930720
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The effect of treatment on circulating immune complexes in rheumatoid arthritis (author's transl)].
    Rosenthal M; Graf U; Müller W
    Dtsch Med Wochenschr; 1977 Mar; 102(12):415-8. PubMed ID: 844411
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gold therapy in rheumatoid arthritis.
    Majoos FL; Klemp P; Meyers OL; Briggs B
    S Afr Med J; 1981 Jun; 59(27):971-4. PubMed ID: 6787722
    [TBL] [Abstract][Full Text] [Related]  

  • 89. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A comparison of low dose levamisole and penicillamine in rheumatoid arthritis.
    Clemens LE; Ansell BM; Bernstein RM; Hall MA; McCauley D
    Aust N Z J Med; 1983 Dec; 13(6):578-82. PubMed ID: 6586147
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.
    Kean WF; Anastassiades TP
    Arthritis Rheum; 1979 May; 22(5):495-501. PubMed ID: 156026
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis.
    Klinefelter HF; Achurra A
    Scand J Rheumatol; 1973; 2(4):177-82. PubMed ID: 4203561
    [No Abstract]   [Full Text] [Related]  

  • 93. Altered thiol status in patients with rheumatoid arthritis.
    Banford JC; Brown DH; Hazelton RA; McNeil CJ; Smith WE; Sturrock RD
    Rheumatol Int; 1982; 2(3):107-11. PubMed ID: 6819630
    [TBL] [Abstract][Full Text] [Related]  

  • 94. An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.
    Paulus HE
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):26-9. PubMed ID: 7065739
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Practical results of treatment with disease-modifying antirheumatoid drugs.
    Thompson PW; Kirwan JR; Barnes CG
    Br J Rheumatol; 1985 May; 24(2):167-75. PubMed ID: 3922462
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis.
    Kvien TK; Høyeraal HM; Sandstad B
    Scand J Rheumatol; 1985; 14(4):346-54. PubMed ID: 3936167
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Remission-inducing therapy in rheumatoid arthritis.
    Lipsky PE
    Am J Med; 1983 Oct; 75(4B):40-9. PubMed ID: 6356907
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Antimalarial drugs for rheumatoid arthritis.
    Mackenzie AH
    Am J Med; 1983 Dec; 75(6A):48-58. PubMed ID: 6362406
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?
    Pullar T; Capell HA
    Ann Rheum Dis; 1985 Feb; 44(2):134-40. PubMed ID: 2858180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.